chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Was doing fine after first after first shot, received 2nd series and next day went to dr. from school complaining of blurred vision, sick to stomach, and bad headache, fever and heart palpitations. Felt like was going to pass out. Went to dr. had tests and was in bed for 3 days. Blood tests came back low.. White, red and platelets.. Told 2 wait and be tested again in a few weeks. When tested again was sent to hospital and then diagnosed with ITP Syndrome and given medication.. Did not work, so then was hospitalized because blood was so low at serious risk for a stroke, was given another dose of globin and spent night at hospital.. A few weeks later, took blood tests again everything was still low, was put on highest dosage of Prednisone 4 3 weeks.. Blood levels raised and stabilized 4 a few weeks.. Latest has been diagnosed with ITP/Evans Syndrome and told would probably turn into Lupus, will have to visit hospital on a regular basis to be monitored.. A permanant disease, Rheumatologist and blood disorder doctors from 2 major hospitals agree this illnes was created by the Gardasil Vaccine and written in their reports.  8/10/09 PCP medical records received DOS 1/2/09 to 3/18/09. Assessment: Low platelet count. Hives/urticaria thighs and lower legs, itching after tanning session. Has started oral contraceptives. Heart palpitations, nausea, feverish. Headache, ears hurt, lightheaded. Looks pale. Excused from PE.  8/10/09 Hospital records and Oncology/Hematology consult, Rheumatology Consult,  DOS 4/9/09 to 4/27/09. Assessment: Thrombocytopenia, anemia, neuropenia, positive lupus anticoagulant, elevated PT/PTT.  Patient presents with thrombocytopenia, anemia, excessive vaginal bleeding. Had bad 'virus' with fevers, cough, headache, poor sleeping and sweating. Missed school. IVIG therapy. Hair is falling out. Energy levels decreased, pale, diffuse bruises, petechia over lower legs. Tightness in neck. Wheezing.  8/10/09 Hematology consult - second opinion, Rheumatology report DOS 4/21/09 to 5/19/09. Assessment: Evan syndrome (autoimmune hemolytic anemia and thrombocytopenia. Patient initially presented with scattered petechia and bruising involving all surfaces of body. Bruising has significantly decreased.  8/10/09 Discharge summary DOS 4/25//09: Assessment: Thrombocytopenia, vaginal bleeding, thrombocytopenia, Autoimmune disorder NOS, hemolytic anemia. Patient presented with platelet count <5. IVIG administered.  4/9/09 Hospital short stay, Pediatric Hematology Clinic visits DOS 4/15/09 to 7/14/09  Assessment: Autoimmune hemolytic anemia and thrombocytopenia. Patient presents with hair coarse and falling out, pale, thrombocytopenia. Headaches, breakthrough vaginal bleeding.  9/4/09 ICD-9 Codes: 287.5 Thrombocytopenia unspecified, 283.9 Acquired hemolytic anemia unspecified, 279.4 Autoimmune disease not elswhere classified,  623.8 Noninflammatory disorder of vagina.
Small raised red 12mm dia, itchy (slight), slightly diminished in depth over time but still sensitive.
Pt received PREVNAR on 5/11/15 on (L) arm. On 5/12 patient experienced swelling and redness down to elbow and back of arm. Area was warm to touch. On 5/18 seen Dr. Was prescribed antibiotic and Naproxen.
Stomach pain, diarrhea and vomiting for about 8 hours. Started feeling better at about 10:00 pm on March 9 and fully recovered by noon on March 10.
Initial unsolicited report received from a nurse via partner company Pfizer (Manufacturer control number: 2016499162) on 01-FEB-2017. This case involves a patient, (age and gender was not reported) who was vaccinated with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (TDAP) (batch number, expiry date, route, dose not reported) and PREVNAR 13 (batch number, expiry date, route, dose not reported) (Manufacturer: Pfizer) in an unknown site on an unknown date. Patient's medical history and concomitant medication was not reported. On an unknown date, after the vaccination, the patient had a reaction. Lab test and corrective treatment was not reported. Documents held by sender: none.
Loosing feeling in my leg and feet; Tingli ness in leg/ tingly ness throughout my finger tips and legs and feet.; Loose feeling in it and my feet would randomly get cold cold; Tiredness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Loosing feeling in my leg and feet), PARAESTHESIA (Tingli ness in leg/ tingly ness throughout my finger tips and legs and feet.), LIMB DISCOMFORT (Loose feeling in it and my feet would randomly get cold cold), FATIGUE (Tiredness) and ARTHRALGIA (joint pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Loosing feeling in my leg and feet), PARAESTHESIA (Tingli ness in leg/ tingly ness throughout my finger tips and legs and feet.), LIMB DISCOMFORT (Loose feeling in it and my feet would randomly get cold cold), FATIGUE (Tiredness) and ARTHRALGIA (joint pain). At the time of the report, HYPOAESTHESIA (Loosing feeling in my leg and feet), PARAESTHESIA (Tingli ness in leg/ tingly ness throughout my finger tips and legs and feet.), LIMB DISCOMFORT (Loose feeling in it and my feet would randomly get cold cold), FATIGUE (Tiredness) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant product were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Significant follow-up received. new events added (limb discomfort, Paraesthesia, fatigue).
I got my shots and my arm hurt so much; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain in extremity (1st dose received on an unknown date, refer case US2021AMR106774).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported this case. The age at vaccination was not reported. The age group was not reported but was captured as per vaccine indication. The patient received shingles shot and his/her arm hurt so much for days. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR106774:same reporter
Patient came to the pharmacy after 4 days of receiving the vaccine and said that the vaccination caused an infection per his Doctor.
chills; sore arm; night sweats; headaches; shakings; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), INJECTION SITE PAIN (sore arm), NIGHT SWEATS (night sweats), HEADACHE (headaches) and TREMOR (shakings) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced CHILLS (chills), INJECTION SITE PAIN (sore arm), NIGHT SWEATS (night sweats), HEADACHE (headaches) and TREMOR (shakings). At the time of the report, CHILLS (chills), INJECTION SITE PAIN (sore arm), NIGHT SWEATS (night sweats), HEADACHE (headaches) and TREMOR (shakings) was resolving.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.   Treatment information not provided.
This spontaneous report was received from a medical assistant referring to a 16 year old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant medication included sterile diluent (manufacturer unknown). On 27-MAR-2018, the patient was administered an improperly stored GARDASIL 9 (lot: N026814; Expiry date: 15-JUL-2020 and lot: N021572; Expiry date: 01-MAY-2020) reconstituted with a properly stored sterile diluent (lot and expiry date not reported) for prophylaxis. The vaccine was exposed to 47 °F to 77°F (67.3°F) for 10 hours, 30 minutes. There was no previous temperature excursion. There was no involvement of digital data logger. This is one of the several reports linked via same reporter link.
Fever; body aches; Joint pain; Headache; severe itching with rash; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 13:15 (at the age of 72-year-old) as single dose for COVID-19 immunisation. Medical history included obesity, copes and arthritis. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), meloxicam (MANUFACTURER UNKNOWN), metoprolol tartrate (LOPRESSOR), vitamin c and vitamin d (MANUFACTURER UNKNOWN), all for unknown indications. The patient had a history of allergy to penicillin, codeine and latex. Since the vaccination, the patient had not been tested for COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Mar2021, at 04:00, the patient experienced fever, body aches, joint pain, headache which were lasted for about 2 days. On an unknown date in 2021, day 8 after the vaccination, the patient had experienced severe itching with rash over her entire body. Therapeutic measures taken as a result of adverse events included Benadryl antihistamine. Adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events fever, body aches, joint pain and headache was resolved in Mar2021 whereas the outcome of severe itching with rash was unknown at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Approximately 12 hours after receiving vaccine, patient's face had a rash on it. Later on that day, patient's rash progressed to her arms and legs. Pt was given ZYRTEC on 9/7/17 in the morning. She was advised by provider to take BENADRYL or other antihistamine.
Soreness and tenderness at injection site; aches in arm, shoulder and neck; minor chills,  considerable swelling under arm and lymph node.
This case was reported by a consumer via call center representative and described the occurrence of shivering in a 56-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of injection site pain (on an unknown date, the patient received 1st dose). On 30th October 2018, the patient received the 2nd dose of SHINGRIX. In October 2018, less than a week after receiving SHINGRIX, the patient experienced shivering. On an unknown date, the outcome of the shivering was unknown. It was unknown if the reporter considered the shivering to be related to SHINGRIX. Additional details were received as follows: The patient was experiencing shivering. The reporter did not consent to follow-up. There was no contact. This case was linked with case US2018198693, reported by the same reporter for the same patient.
Flat based single ulcer; Painful vaginal ulcer noted in the evening, present for one week
I began having a rash wrapping around my arm from where the injection site was at the same day that I received the vaccination and it traveled all over my body and the bottom of my feet began to swell in April and it has been on going.  The rash inflamed and hot in touch it traveled to different parts of my body and I dealt with it a couple days on my own taking Benadryl and I went to the ED on April 9th I am not a scratcher but it would blow up because I scratched in that area. I thought it was done for but I started getting itchy yesterday and the day before.
pt recv vax 13SEP96 & 8APR(7 pt devel a rash that consisted of sl less than 50 lesions & no fever;
Information has been received from a physician concerning an eight year old Hispanic male pt who on 02Aug99 was vaccinated with varicella virus vaccine live (lot628695/1671H). The physician reported that last week, on 02May05, the pt came into the office with a very mild breakthrough case of chicken pox. No treatment was given. There was no other information regarding the adverse experience. There was no product quality complaint reported. Additional information has been requested. Information has been received from a physician concerning an eight-year-old male patient who on 02-AUG-1999, was vaccinated with VARIVAX (Merck) (Lot# 638695/1671H). There were no concomitant medications. The physician reported that last week, on 02-MAY-2005, the patient came into the office with a very mild breakthrough case of chicken pox. No treatment was given. There was no other information regarding the adverse experience. There was no product quality comlaint reported. Follow up information received from the physician reported the patient did not undergo any lab/diagnostic tests. The only reported adverse reaction were ther varicella lesions, a few lesions with no fever or pruitis. Additional information is not expected.
Patient received 1st dose of Moderna based on patients age should have been Pfizer. The father of the patient requested Moderna.
a 12YO patient vaccinated with Pediarix; vaccinated with Pediarix instead of Boostrix; This case was reported by a other health professional and described the occurrence of inappropriate age at vaccine administration in a 12-year-old patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 24th November 2021, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 24th November 2021, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: Other health professional reported a 12 year patient was vaccinated with Pediarix instead of Boostrix which led to wrong vaccine administration and inappropriate age at vaccine administration. The reporter didn't feel comfortable giving patient's personal information. The reporter did not give consent to follow up because she does not believe it was necessary.
Patient stated that 2 hours after receiving the vaccine he had a fogginess in his brain. He stated that he wanted  to cry for no reason.
After almost 10 days after the injection my neck was in a lot of pain. I couldn?t turn it. Soon afterwards, the whole left side of my neck swelled up including near the clavicle of my neck. My initial symptom after the vaccine was only a sore arm and headache.
Swelling, red, firm, hurts to touch:  around the shot site on my arm
PT HAD SIGNIFICANT DIARRHEA AND VOMITING THE DAY AFTER RECEIVING THE VACCINE.  UNDERNEATH HER TONGUE WHERE IT CONNECTS TO THE MOUTH SEEMED A LITTLE SWOLLEN.
slight fever; Headache; chills; aches; joint pain; This is a spontaneous report from a contactable nurse (patient). A 63-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number-EL3246), via an unspecified route of administration on left arm at 10:30 AM on 07Jan2021 at single dose for COVID-19 immunization. Medical history included thyroid disorder and known allergies: PCN (Penicillin). Concomitant medication included levothyroxine sodium (SYNTHROID), curcumin and vitamins. The patient previously received her first dose of BNT162B2 (lot number=EH9899) on left arm at 10:45 AM on 17Dec2020 for COVID-19 immunization. The patient experienced headache, chills, aches and joint pain with slight fever on 07Jan2021 at 22:00. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any treatment for events. The outcome of events was recovered in Jan2021.
On 12/11/2022 I noticed a little sore throat around 08:00PM. I woke up later that night and could tell I was stuffy. While getting ready for work the next day, I tested myself for COVID-19. To my surprise, it was positive. That same day, I went into work for a PCR test which was also positive. I spoke with a fellow healthcare provider from work. We discussed that my symptoms did not seem sever enough for antiviral treatment. As the day wore on, I began to feel worse. I took some ADVIL 2 at least twice that day. Monday night, I had a fever and chills. I went to get THERAFLU the next day and have been taking it every six to eight hours. When I don't take it, I get sneezing, coughing and body aches but the medication does seem to be helping.
The stomach is not normal; Vertigo; nausea; Fatigue/very fatigued; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (The stomach is not normal), VERTIGO (Vertigo), NAUSEA (nausea), FATIGUE (Fatigue/very fatigued) and HEADACHE (Headaches) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (The stomach is not normal), VERTIGO (Vertigo), NAUSEA (nausea), FATIGUE (Fatigue/very fatigued) and HEADACHE (Headaches). At the time of the report, ABDOMINAL DISCOMFORT (The stomach is not normal) and VERTIGO (Vertigo) outcome was unknown and NAUSEA (nausea), FATIGUE (Fatigue/very fatigued) and HEADACHE (Headaches) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Ibuprofen.  This case concerns a female of unknown age with unexpected abdominal discomfort and expected nausea and fatigue. Event onset with unknown latency. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-272419 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up received: Significant FU-Patient Age provided, Vertigo and  headache added as adverse event as per phone call follow up reply; Sender's Comments: This case concerns a female of unknown age with unexpected abdominal discomfort and expected nausea and fatigue. Event onset with unknown latency. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
preseptal cellulitis/left facial cellulitis; facial asymmetry; sagging of left upper lid; This case was reported by a physician via call center representative and described the occurrence of preseptal cellulitis in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of periorbital cellulitis (1st dose received in December 2019, refer case US2021018328).   In July 2020, the patient received the 2nd dose of Shingrix. In July 2020, 1 week after receiving Shingrix, the patient experienced preseptal cellulitis (serious criteria GSK medically significant). On an unknown date, the patient experienced facial asymmetry and sagging eyelid skin. The patient was treated with amoxicillin sodium, potassium clavulanate (Augmentin) and sulfamethoxazole + trimethoprim (Bactrim). Rechallenge with Shingrix was positive. In August 2020, the outcome of the preseptal cellulitis was resolved with sequelae. On an unknown date, the outcome of the facial asymmetry and sagging eyelid skin were not recovered/not resolved.   The reporter considered the preseptal cellulitis to be almost certainly related to Shingrix. It was unknown if the reporter considered the facial asymmetry and sagging eyelid skin to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported but could be 54 or 55 years. The physician stated that because of COVID epidemics the delivery of the 2nd dose was delayed till July 2020/ some 6 months later. The patient about 1 week later of vaccination, developed preseptal cellulitis and was treated successfully with combination of oral Bactrim and Augmentin for 10 days. The physician stated that less than 9 months after receiving Shingrix, some facial asymmetry and sagging of left upper lid persisted. In August 2020, CT brain done had not revealed any significant abnormalities. The physician stated that the patient never suffered preseptal cellulitis before or after these two episodes. The reporter consented to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021018328:Same reporter
Rash to chest, abdomen, and forearms noted yesterday. Client stopped in the office this morning to show staff. She is going to see healthcare provider today.
Severe headache the night after vaccination.  Cold symptoms including sinus pain, headache, and nasal congestion for 6 days following vaccination.  Chickenpox-like rash beginning on 6th day after vaccination. Red, raised, itchy bumps started on abdomen and have spread to sides, back, breasts, chest, arms and upper thighs.
Within seconds of receiving 4th dose of vaccine right arm swelled up; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative. The reporter is the patient.  A 59-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) at the age of 59 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "recovered", described as "Within seconds of receiving 4th dose of vaccine right arm swelled up". The event "within seconds of receiving 4th dose of vaccine right arm swelled up" required physician office visit. Therapeutic measures were not taken as a result of peripheral swelling.  Additional information: The suspect vaccine patient received was not bivalent.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.